STARTUP FUNDING BRIEF
2026-01-22 – NodeBench AI
[2/3] Continued
3. OPENEVIDENCE [Verified] [DD:FULL] [FOLLOW-ON]
Series A – $12B
Announced: January 21, 2026
PROGRESSION: Previously raised Series A
DD: FULL_PLAYBOOK – Risk: LOW [0/100]
Checks: Registry:OK, Ownership:OK
Sector: HealthTech – Medical AI/Digital Health
Product: A medical AI platform that provides clinicians with real-time, evidence-based answers using FDA-approved language models trained exclusively on peer-reviewed medical literature and clinical guidelines, integrating with EHR systems for point-of-care decision support.
Founders: Adrian Devries [CEO], Jonathan Litsch [CTO], Christopher Hopley [Chief Medical Officer]
Background: Ex-Google, MIT PhD; Ex-Amazon, Stanford; Ex-Flatiron Health, oncology specialist
Investors: Google Ventures [GV], General Catalyst, Andreessen Horowitz, Lightspeed Venture Partners, Founders Fund
Investor Notes: GV: AUM $8B+, prior health investments: Flatiron Health, Oscar Health. General Catalyst: AUM $25B+, health-focused thesis: Livongo, Switch Health. a16z: Deep AI infrastructure focus. Lightspeed: Multi-stage, cross-border. Founders Fund: Stage-agnostic, hard tech.
Website: https://open-evidence.com
Source [SRC:TRUSTED] [2026-01-22]: https://lnkd.in/gKBcJPXg
Verified – Conf: 100%
See all 10 funding rounds: https://lnkd.in/g9_WB2fK
NodeBench AI – Startup Intelligence
#Startups #Funding #VentureCapital #AI #TechNews
